Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 4/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 6/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3467999 | 1.00 | CHRM1 (0.43) | CHRM1CHRM2CHRM3SLC6A2SLC6A4 | |
| SCHEMBL1358479 | 0.87 | DRD2 (0.47) | CHRM2HTR3ACYP2D6HRH1DRD3 | |
| SCHEMBL16836614 | 0.80 | KEAP1 (0.47) | — | |
| SCHEMBL743844 | 0.80 | POLB (0.49) | — | |
| SCHEMBL16286910 | 0.78 | CHRM1 (0.49) | CHRM1CHRM2CHRM3SLC6A2SLC6A4 | |
| SCHEMBL16286908 | 0.78 | CHRM1 (0.49) | CHRM1CHRM2CHRM3SLC6A2SLC6A4 | |
| SCHEMBL7440323 | 0.77 | HTR3A (0.45) | CHRM1CHRM2CHRM3SLC6A2SLC6A4 | |
| SCHEMBL7973793 | 0.76 | HTR3E (0.40) | CHRM1CHRM2CHRM3HTR3ACYP2D6 | |
| SCHEMBL7973796 | 0.76 | HTR3E (0.40) | CHRM1CHRM2CHRM3HTR3ACYP2D6 | |
| SCHEMBL17752643 | 0.74 | HTR3A (0.50) | CHRM1CHRM2CHRM3SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | claimed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | claimed |
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | disclosed |
| US-10271540-B2 | Medical fluid, a method of treatment and use of the fluid | XVIVO PERFUSION AB (SE) | 2019-04-30 | — | — | US | disclosed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | disclosed |
| US-20160338343-A1 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2016-11-24 | — | — | US | disclosed |
| US-20130065218-A1 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | VIVOLINE MEDICAL AB (SE) | 2013-03-14 | — | — | US | disclosed |
| WO-2010077201-A1 | A COMPOSITION COMPRISING NOR-ADRENALINE AND AMPHETAMINE FOR ADMINISTERING TO A BRAIN-DEAD, HEART -BEATING POTENTIAL ORGAN DONOR | IGELÖSA TRANSPLANTATION SCIENCE AB (SE) | 2010-07-08 | — | — | WO | disclosed |